Literature DB >> 8285211

Citrate and calcium effects on Tamm-Horsfall glycoprotein as a modifier of calcium oxalate crystal aggregation.

B Hess1, L Zipperle, P Jaeger.   

Abstract

We measured the effects of Tamm-Horsfall glycoprotein (THP) on calcium oxalate monohydrate (COM) crystal aggregation (Ac) in vitro as well as intrinsic viscosities (Vi) of THP at pH 5.7 and 200 mM NaCl and studied the effects of calcium and citrate on these parameters. THP were isolated from 24-h urines of seven male recurrent calcium stone formers (RCSF) and eight age-matched male healthy volunteers (N, normal). At basal conditions, RCSF-THP inhibited Ac by 28 +/- 10% and normal THP by 60 +/- 6% (P = 0.028). In the presence of calcium, increasing THP concentrations from 16 to 28 and 40 mg/l progressively lowered inhibition by RCSF-THP, but not by N-THP. At 40 mg/l, inhibition by N-THP was 27 +/- 9% vs. -43 +/- 8% by RCSF-THP (P = 0.001), i.e., all stone former THP promoted Ac. With an additional 3.5 mM of citrate, inhibition of Ac was 56 +/- 5% by normal and 34 +/- 6% by stone former THP (P = 0.021), and all seven stone former THP again inhibited Ac. Vi of RCSF-THP was higher than that of N at basal conditions (162 +/- 21 vs. 93 +/- 15 ml/g, P = 0.021) and in the presence of 5 mM calcium (352 +/- 54 vs. 118 +/- 17 ml/g, P = 0.001), i.e., RCSF-THP were more self-aggregated, but not when citrate was added (185 +/- 29 vs. 123 +/- 19 ml/g). (ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8285211     DOI: 10.1152/ajprenal.1993.265.6.F784

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

1.  An evaluation of Tamm-Horsfall protein glycans in kidney stone formers using novel techniques.

Authors:  Sulabha Argade; Tony Chen; Timothy Shaw; Zoltan Berecz; William Shi; Biswa Choudhury; C Lowell Parsons; Roger L Sur
Journal:  Urolithiasis       Date:  2015-05-03       Impact factor: 3.436

2.  Calcium Oxalate Stone Agglomeration Inhibition [tm] Reflects Renal Stone-Forming Activity.

Authors:  J S Lindberg; F E Cole; W Romani; F E Husserl; H A Fuselier; D J Kok; D T Erwin
Journal:  Ochsner J       Date:  2000-04

3.  Aggregation of freshly precipitated calcium oxalate crystals in urine of calcium stone patients and controls.

Authors:  J M Baumann; B Affolter; R Casella
Journal:  Urol Res       Date:  2011-05-13

4.  Isoelectric focusing of Tamm-Horsfall glycoproteins: a simple tool for recognizing recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle; F Hering; H Seiler
Journal:  Urol Res       Date:  1996

Review 5.  Intratubular crystallization events.

Authors:  D J Kok
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  Kinetics of calcium oxalate crystal formation in urine.

Authors:  Norbert Laube; Florian Klein; Falk Bernsmann
Journal:  Urolithiasis       Date:  2016-06-21       Impact factor: 3.436

7.  Immunocytochemical localization of Tamm-Horsfall protein in the kidneys of normal and nephrolithic rats.

Authors:  J A Gokhale; M D McKee; S R Khan
Journal:  Urol Res       Date:  1996

8.  A simple diagnostic method for the differentiation of Tamm-Horsfall glycoproteins from healthy probands and those from recurrent calcium oxalate renal stone formers.

Authors:  P Schnierle
Journal:  Experientia       Date:  1995-11-15

9.  Surface aggregation of urinary proteins and aspartic Acid-rich peptides on the faces of calcium oxalate monohydrate investigated by in situ force microscopy.

Authors:  Matthew L Weaver; S Roger Qiu; John R Hoyer; William H Casey; George H Nancollas; James J De Yoreo
Journal:  Calcif Tissue Int       Date:  2009-03-18       Impact factor: 4.333

Review 10.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.